-
When not constrained by your clinic's formulary, which oral contraceptive (OC) do you pick for a 21-year-old nonsmoking woman? Look to Ortho Tri-Cyclen Lo (Ortho-McNeil Pharmaceutical; Raritan, NJ), which continues its No. 1 spot in the 2009 Contraceptive Technology Update Contraception Survey.
-
The next woman in your exam room says she has had cramping, breast tenderness, and headaches during the pill-free placebo week of her oral contraceptive (OC). She is open to having less frequent withdrawal bleeding. What's your next move?
-
-
This issue marks the 30th anniversary of Contraceptive Technology Update.
-
Look back to results of the 2004 Contraceptive Technology Update Contraception Survey: Just 30% of survey respondents said they inserted six or more intrauterine contraceptives in the past year.
-
In December 2009, the American College of Obstetricians and Gynecologists (ACOG ) released a clinical management guideline recommending changes to cervical cancer screening guidelines.
-
Health care providers have struggled with instituting routine HIV screening for adolescents and most adults since the Centers for Disease Control and Prevention (CDC), recommended such testing for everyone between 13 and 64 years of age in 2006.
-
As HIV clinicians in Cleveland, OH, were testing a symptom management intervention, they found there weren't any good scales available.
-
The National Institutes of Health and the city of Washington, D.C. recently announced the new D.C. Partnership for HIV/AIDS Progress, a collaborative research initiative between NIH and the D.C. Department of Health designed to decrease the rate of new HIV infections in the city, improve the health of district residents living with HIV infection, and strengthen the city's response to the HIV/AIDS epidemic.
-
